Literature DB >> 21400518

Tumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF-α and melphalan.

Florian Grabellus1, Corinna Kraft, Sien-Yi Sheu-Grabellus, Sebastian Bauer, Lars E Podleska, Thomas C Lauenstein, Christoph Pöttgen, Margarethe J Konik, Kurt W Schmid, Georg Taeger.   

Abstract

BACKGROUND: Isolated limb perfusion (TM-ILP) achieves high response rates in soft tissue sarcomas (STS). Some tumors show an insufficient association between radiological and pathological response. We investigated STS after TM-ILP with a primary emphasis on histologic regression patterns.
METHODS: In 53 patients with STS, TM-ILP with subsequent tumor resection was performed. Regression was assessed by the Salzer-Kuntschik regression scale. Microvessel density (MVD) of primary biopsies of 37 patients was determined by immunohistochemistry. Tumor regression was correlated with MVD of primary biopsies and other clinico-pathological parameters.
RESULTS: Regression presented mainly as necrosis or fibrosis/sclerosis upon histopathology. MFH, leiomyosarcoma, or clear cell sarcoma (CCS) responded well; whereas liposarcomas, synovial sarcomas, or MPNST were poor responders. MFH often had abundant necrosis; while other STS mainly presented with fibrosis/sclerosis. MVD had no influence on regression grade but modulated histologic regression patterns. Excellent regression demonstrated a trend toward an association with improved survival and local control.
CONCLUSION: TM-ILP yielded high response rates in STS. Regression after TM-ILP exhibits MVD-dependent histopathologic patterns and variable efficacy in different sarcoma types. Complete regression seems to be a favorable prognostic factor. A concerted consideration of histopathology and clinical findings may contribute to a better clinical assessment of regression after TM-ILP.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21400518     DOI: 10.1002/jso.21724

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan.

Authors:  Dimosthenis Andreou; Henrike Boldt; Daniel Pink; Björn Jobke; Mathias Werner; Markus Schuler; Peter Reichardt; Per-Ulf Tunn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-12       Impact factor: 9.236

2.  Chemotherapy influences the pseudocapsule composition in soft tissue sarcomas.

Authors:  Patrick W O'Donnell; J Carlos Manivel; Edward Y Cheng; Denis R Clohisy
Journal:  Clin Orthop Relat Res       Date:  2014-03       Impact factor: 4.176

3.  TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature.

Authors:  L E Podleska; K Funk; L Umutlu; F Grabellus; G Taeger; H de Groot
Journal:  Br J Cancer       Date:  2015-07-14       Impact factor: 7.640

4.  Drug dosage in isolated limb perfusion: evaluation of a limb volume model for extremity volume calculation.

Authors:  Lars Erik Podleska; Thorsten Poeppel; Michael Herbrik; Lisa Dahlkamp; Florian Grabellus; Georg Taeger
Journal:  World J Surg Oncol       Date:  2014-04-01       Impact factor: 2.754

Review 5.  The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets.

Authors:  Laura Rocchi; Stefano Caraffi; Roberto Perris; Domenica Mangieri
Journal:  Biosci Rep       Date:  2014-11-04       Impact factor: 3.840

6.  Lower limb function and quality of life after ILP for soft-tissue sarcoma.

Authors:  Lars Erik Podleska; Nevda Kaya; Farhad Farzaliyev; Christoph Pöttgen; Sebastian Bauer; Georg Taeger
Journal:  World J Surg Oncol       Date:  2017-04-13       Impact factor: 2.754

7.  The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas.

Authors:  Benjamin Schwindenhammer; Lars Erik Podleska; Andrea Kutritz; Sebastian Bauer; Sien-Yi Sheu; Georg Taeger; Kurt Werner Schmid; Florian Grabellus
Journal:  World J Surg Oncol       Date:  2013-08-12       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.